Efficacy and Impact of Botulinum Toxin A Versus Anticholinergic Therapy for the Treatment of Bothersome Urge Urinary Incontinence.

Trial Profile

Efficacy and Impact of Botulinum Toxin A Versus Anticholinergic Therapy for the Treatment of Bothersome Urge Urinary Incontinence.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Sep 2013

At a glance

  • Drugs Botulinum toxin A (Primary) ; Solifenacin; Trospium chloride
  • Indications Overactive bladder; Urge incontinence
  • Focus Therapeutic Use
  • Acronyms ABC
  • Most Recent Events

    • 30 Aug 2013 Results presented at the 43rd Annual Meeting of the International Continence Society.
    • 04 Oct 2012 Results published in the New England Journal of Medicine.
    • 04 Oct 2012 Primary endpoint 'Frequency-of-incontinence-episodes' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top